Author
Listed:
- Liang-Yu Chen
(Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan
School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan)
- Huey-Juan Lin
(Department of Neurology, Chi-Mei Medical Center, Tainan City 710, Taiwan)
- Wen-Tung Wu
(Department of Pharmacy Practice, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114, Taiwan
School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan)
- Yong-Chen Chen
(Department of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan
Big Data Research Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan)
- Cheng-Li Chen
(School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan)
- Jing Kao
(School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan)
- San-Lin You
(Department of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan
Big Data Research Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan)
- Yu-Ching Chou
(School of Public Health, National Defense Medical Center, Taipei City 114, Taiwan)
- Chien-An Sun
(Big Data Research Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan
Department of Public Health, College of Medicine, Fu-Jen Catholic University, New Taipei City 242, Taiwan)
Abstract
Background: Results of studies regarding the potential link between acid suppressant use and dementia risk are inconsistent. This study aimed to evaluate the association of cumulative exposure to histamine 2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) with dementia risk in an Asian older cohort aged ≥65 years. Methods: Patients initiating H2RA (the H2RA user cohort, n = 21,449) or PPI (the PPI user cohort, n = 6584) and those without prescription for H2RA (the H2RA non-user cohort, n = 21,449) or PPI (the PPI non-user cohort, n = 6584) between 1 January 2000 and 31 December 2005 without a prior history of dementia were identified from Taiwan’s National Health Insurance Research Database (NHIRD). The outcome of interest was all-cause dementia. Patients’ exposure to H2RAs or PPIs was followed-up from dates of initial prescription to the earliest outcome of incident dementia, death, or the end of 2013. Potential associations between acid suppressant use and dementia risk were analyzed using time-dependent Cox regression estimated hazard ratios (HRs) and 95% confidence intervals (CIs). Results: After mutual adjustment for H2RA and PPI use and other potential confounders, patients with H2RA use had significantly higher risk of developing dementia as compared to those not treated with H2RAs (adjusted HR, 1.84; 95% CI, 1.49–2.20). Likewise, PPI users had significantly elevated risk of dementia compared to PPI non-users (adjusted HR, 1.42; 95% CI, 1.07–1.84). Conclusions: Our results indicate that exposures to H2RAs and PPIs are associated with increased dementia risk.
Suggested Citation
Liang-Yu Chen & Huey-Juan Lin & Wen-Tung Wu & Yong-Chen Chen & Cheng-Li Chen & Jing Kao & San-Lin You & Yu-Ching Chou & Chien-An Sun, 2020.
"Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study,"
IJERPH, MDPI, vol. 17(21), pages 1-12, November.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:21:p:8271-:d:442074
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:21:p:8271-:d:442074. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.